Pioneering 3D Human Tissues for Drug Discovery
Jul 16 | 2024
Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis
Read More »May 21 | 2024
Jul 16 | 2024
May 21 | 2024